Senior Specialist, Annual Product Quality Review (APQR) at Bristol-Myers Squibb

Hyderabad, Telangana, India

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • Understanding of Biologics, Pharmaceutical, and/or Cell Therapy operations and processes
  • Experience in a GMP Quality role
  • Experience in authoring APQRs
  • Prior experience with navigating Quality Management systems
  • Demonstrated tactical thinking capability with strong project management skills
  • Ability to work in a global environment
  • Demonstrated negotiating and influencing skills in a matrixed organization
  • Ability to build strong relationships by being transparent, reliable, and delivering on commitments
  • Effective communication skills
  • Ability to provide innovative ideas, align and make decisions balancing speed, quality, and risk
  • Fluent in English, with proven professional working proficiency in English for reading, writing, and speaking
  • Minimum 3 years of experience in a technical, quality, and/or regulatory role within the biopharmaceutical industry with demonstrated acumen in Quality Compliance or Operations preferred
  • Ability to travel

Responsibilities

  • Manage the Global BMS site APQR program by leading and generating APQRs for all commercial Marketed Products
  • Lead a team of Subject Matter Experts to draft and complete APQRs from draft to final approval and delivery to key stakeholders per schedule
  • Provide oversight and completion of site APQRs
  • Author assigned site APQRs per schedule
  • Ensure site or CMO APQRs are created following effective processes and procedures
  • Provide in-depth quality and compliance oversight during report authoring
  • Ensure all elements of the APQR procedure are fulfilled accurately
  • Facilitate review and approval meetings, problem-solve key issues, and manage communications with key stakeholders
  • Collect review feedback and resolve comments and questions
  • Project and communicate stakeholder actions and timing
  • Escalate deficiencies in the draft APQR that cannot be resolved with the working team
  • Escalate risks to not meeting the completion date
  • Provide opportunities for process improvement
  • Adhere to GMPs and BMS Policies and Procedures
  • Support implementation and/or maintenance of additional QA Systems (e.g., APQR program documentation, Change Control, Quality Risk Management, Product Quality Complaints)
  • Support digitalization/automation efforts for the APQR program

Skills

APQR
Annual Product Quality Review
Quality Oversight
Compliance
Report Authoring
Stakeholder Management
SME Coordination
GMP
Pharmaceutical Manufacturing

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI